ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Extramural Programs: NCAB Approves Guidelines for Cancer Center Grants

March 7, 1997

Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction

August 31, 2007

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Committee Drafts QRA Definition

November 19, 1982

In Brief: Hatch Introduces Bill Banning Smoking On U.S. Public Conveyances; New OCC Staff Announced

January 16, 1987

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005